|
CLIC4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.973700E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.341800E-03 |
| Normal-vs-Stage2 |
4.512800E-01 |
| Normal-vs-Stage3 |
7.542000E-01 |
| Normal-vs-Stage4 |
5.739800E-01 |
| Stage1-vs-Stage2 |
7.263000E-01 |
| Stage1-vs-Stage3 |
4.435600E-02 |
| Stage1-vs-Stage4 |
5.579900E-03 |
| Stage2-vs-Stage3 |
5.702600E-01 |
| Stage2-vs-Stage4 |
3.181800E-01 |
| Stage3-vs-Stage4 |
4.444200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.739900E-02 |
| Normal-vs-AfricanAmerican |
9.822100E-02 |
| Normal-vs-Asian |
6.643000E-01 |
| Caucasian-vs-AfricanAmerican |
8.999900E-04 |
| Caucasian-vs-Asian |
9.905800E-01 |
| AfricanAmerican-vs-Asian |
2.090400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.754800E-01 |
| Normal-vs-Female |
2.526400E-02 |
| Male-vs-Female |
1.950800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.094800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.231900E-02 |
| Normal-vs-Age(61-80Yrs) |
3.754200E-01 |
| Normal-vs-Age(81-100Yrs) |
5.706600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.901800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.458000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.616000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.151800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.252400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.811400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.395600E-03 |
| Normal-vs-Grade 2 |
3.436000E-03 |
| Normal-vs-Grade 3 |
2.683000E-01 |
| Normal-vs-Grade 4 |
2.081600E-02 |
| Grade 1-vs-Grade 2 |
2.625200E-01 |
| Grade 1-vs-Grade 3 |
6.102000E-02 |
| Grade 1-vs-Grade 4 |
2.408700E-04 |
| Grade 2-vs-Grade 3 |
3.522200E-02 |
| Grade 2-vs-Grade 4 |
1.01580000000379E-06 |
| Grade 3-vs-Grade 4 |
1.538490E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.90469999772347E-08 |
| Normal-vs-ccB subtype |
1.443950E-01 |
| ccA subtype-vs-ccB subtype |
3.12080361553058E-11 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.260100E-02 |
| Normal-vs-N1 |
5.001000E-01 |
| N0-vs-N1 |
2.251000E-01 |
|
|
